• Mashup Score: 0

    As you were browsing www.anesthesiologynews.com something about your browser made us think you were a bot. There are a few reasons this might happen: You’re a power user moving through this website with super-human speed. You’ve disabled JavaScript in your web browser. A third-party browser plugin,…

    Tweet Tweets with this article
    • Switching from #neostigmine to #sugammadex as the standard reversal agent during #anesthesia linked to decreased risk for composite respiratory outcome. https://t.co/gp1DYgHkST @CUAnschutz @JohnsHopkins

  • Mashup Score: 0

    As you were browsing www.anesthesiologynews.com something about your browser made us think you were a bot. There are a few reasons this might happen: You’re a power user moving through this website with super-human speed. You’ve disabled JavaScript in your web browser. A third-party browser plugin,…

    Tweet Tweets with this article
    • Switching from #neostigmine to #sugammadex as the standard reversal agent during #anesthesia linked to decreased risk for composite respiratory outcome. https://t.co/gp1DYgHkST @CUAnschutz @JohnsHopkins

  • Mashup Score: 3

    As you were browsing www.anesthesiologynews.com something about your browser made us think you were a bot. There are a few reasons this might happen: You’re a power user moving through this website with super-human speed. You’ve disabled JavaScript in your web browser. A third-party browser plugin,…

    Tweet Tweets with this article
    • An analysis found that sugammadex gained broad clinical support for reversal of neuromuscular blockade shortly after its FDA approval. https://t.co/Gmyecd78LO @Merck @UMich @MichaelMAzizMD1 #fda #sugammadex #neuromuscular